<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>156(12)</volume><submitter>Gertsen EC</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>The optimal staging for gastric cancer remains a matter of debate.&lt;h4>Objective&lt;/h4>To evaluate the value of 18F-fludeoxyglucose-positron emission tomography with computed tomography (FDG-PET/CT) and staging laparoscopy (SL) in addition to initial staging by means of gastroscopy and CT in patients with locally advanced gastric cancer.&lt;h4>Design, setting, and participants&lt;/h4>This multicenter prospective, observational cohort study included 394 patients with locally advanced, clinically curable gastric adenocarcinoma (≥cT3 and/or N+, M0 category based on CT) between August 1, 2017, and February 1, 2020.&lt;h4>Exposures&lt;/h4>All patients underwent an FDG-PET/CT and/or SL in addition to initial staging.&lt;h4>Main outcomes and measures&lt;/h4>The primary outcome was the number of pat</pubmed_abstract><journal>JAMA surgery</journal><pagination>e215340</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8552113</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC).</pubmed_title><pmcid>PMC8552113</pmcid><pubmed_authors>Daams F</pubmed_authors><pubmed_authors>Bouwmeester E</pubmed_authors><pubmed_authors>Profar J</pubmed_authors><pubmed_authors>Wessels FJ</pubmed_authors><pubmed_authors>Tummers S</pubmed_authors><pubmed_authors>Pierie JP</pubmed_authors><pubmed_authors>Siersema PD</pubmed_authors><pubmed_authors>de Mooij K</pubmed_authors><pubmed_authors>van Hillegersberg R</pubmed_authors><pubmed_authors>van Det MJ</pubmed_authors><pubmed_authors>van Laarhoven HWM</pubmed_authors><pubmed_authors>Hartgrink HH</pubmed_authors><pubmed_authors>Vegt E</pubmed_authors><pubmed_authors>Eker HH</pubmed_authors><pubmed_authors>Heisterkamp J</pubmed_authors><pubmed_authors>Heijmans M</pubmed_authors><pubmed_authors>Pijpers J</pubmed_authors><pubmed_authors>Luyer MDP</pubmed_authors><pubmed_authors>Masselink I</pubmed_authors><pubmed_authors>Wevers KP</pubmed_authors><pubmed_authors>van Kleef JJ</pubmed_authors><pubmed_authors>van den Berg JW</pubmed_authors><pubmed_authors>van Dam M</pubmed_authors><pubmed_authors>van Duijvendijk P</pubmed_authors><pubmed_authors>van der Peet DL</pubmed_authors><pubmed_authors>Frederix GWJ</pubmed_authors><pubmed_authors>van Berge Henegouwen MI</pubmed_authors><pubmed_authors>Hol L</pubmed_authors><pubmed_authors>van Groenestyn A</pubmed_authors><pubmed_authors>Spillenaar Bilgen EJ</pubmed_authors><pubmed_authors>Nieuwenhuijzen GAP</pubmed_authors><pubmed_authors>Thijssen AY</pubmed_authors><pubmed_authors>Brenkman HJF</pubmed_authors><pubmed_authors>Kouwenhoven EA</pubmed_authors><pubmed_authors>van Grieken NCT</pubmed_authors><pubmed_authors>de Steur WO</pubmed_authors><pubmed_authors>Gisbertz SS</pubmed_authors><pubmed_authors>Wijnhoven BPL</pubmed_authors><pubmed_authors>Ruurda JP</pubmed_authors><pubmed_authors>van Etten B</pubmed_authors><pubmed_authors>Prins M</pubmed_authors><pubmed_authors>Gertsen EC</pubmed_authors><pubmed_authors>van Lanschot JJB</pubmed_authors><pubmed_authors>Hulsewe KWE</pubmed_authors><pubmed_authors>Lagarde SM</pubmed_authors><pubmed_authors>PLASTIC Study Group</pubmed_authors><pubmed_authors>Wassenaar E</pubmed_authors><pubmed_authors>de Vries N</pubmed_authors><pubmed_authors>Haj Mohammad N</pubmed_authors><pubmed_authors>van der Meulen MP</pubmed_authors><pubmed_authors>Beumer D</pubmed_authors><pubmed_authors>van Sandick JW</pubmed_authors><pubmed_authors>Belt EJT</pubmed_authors><pubmed_authors>Stoot JHMB</pubmed_authors></additional><is_claimable>false</is_claimable><name>18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC).</name><description>&lt;h4>Importance&lt;/h4>The optimal staging for gastric cancer remains a matter of debate.&lt;h4>Objective&lt;/h4>To evaluate the value of 18F-fludeoxyglucose-positron emission tomography with computed tomography (FDG-PET/CT) and staging laparoscopy (SL) in addition to initial staging by means of gastroscopy and CT in patients with locally advanced gastric cancer.&lt;h4>Design, setting, and participants&lt;/h4>This multicenter prospective, observational cohort study included 394 patients with locally advanced, clinically curable gastric adenocarcinoma (≥cT3 and/or N+, M0 category based on CT) between August 1, 2017, and February 1, 2020.&lt;h4>Exposures&lt;/h4>All patients underwent an FDG-PET/CT and/or SL in addition to initial staging.&lt;h4>Main outcomes and measures&lt;/h4>The primary outcome was the number of pat</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-26T10:42:14.794Z</modification><creation>2025-04-06T13:27:55.108Z</creation></dates><accession>S-EPMC8552113</accession><cross_references><pubmed>34705049</pubmed><doi>10.1001/jamasurg.2021.5340</doi></cross_references></HashMap>